Zobrazeno 1 - 9
of 9
pro vyhledávání: '"CI Edvard Smith"'
Autor:
Oscar P. B. Wiklander, Joel Z. Nordin, Aisling O'Loughlin, Ylva Gustafsson, Giulia Corso, Imre Mäger, Pieter Vader, Yi Lee, Helena Sork, Yiqi Seow, Nina Heldring, Lydia Alvarez-Erviti, CI Edvard Smith, Katarina Le Blanc, Paolo Macchiarini, Philipp Jungebluth, Matthew J. A. Wood, Samir EL Andaloussi
Publikováno v:
Journal of Extracellular Vesicles, Vol 4, Iss 0, Pp 1-8 (2015)
Extracellular vesicles (EVs) have emerged as important mediators of intercellular communication in a diverse range of biological processes. For future therapeutic applications and for EV biology research in general, understanding the in vivo fate of
Externí odkaz:
https://doaj.org/article/0d7374c1eade4f03b61583b05e54f879
Autor:
Helena Sork, Joel Z Nordin, Janne J Turunen, Oscar PB Wiklander, Burcu Bestas, Eman M Zaghloul, Helerin Margus, Kärt Padari, Adil D Duru, Giulia Corso, Jeremy Bost, Pieter Vader, Margus Pooga, CI Edvard Smith, Matthew JA Wood, Raymond M Schiffelers, Mattias Hällbrink, Samir EL Andaloussi
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 5, Iss C (2016)
The advantages of lipid-based transfection reagents have permitted their widespread use in molecular biology and gene therapy. This study outlines the effect of cryo-manipulation of a cationic lipid-based formulation, Lipofectamine 2000, which, after
Externí odkaz:
https://doaj.org/article/48a6da84132a4f1db17f5fc1b93f1a61
Autor:
Sofia Stenler, Oscar PB Wiklander, Maria Badal-Tejedor, Janne Turunen, Joel Z Nordin, David Hallengärd, Britta Wahren, Samir EL Andaloussi, Mark W Rutland, CI Edvard Smith, Karin E Lundin, Pontus Blomberg
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 3, Iss C (2014)
The minicircle (MC), composed of eukaryotic sequences only, is an interesting approach to increase the safety and efficiency of plasmid-based vectors for gene therapy. In this paper, we investigate micro-MC (miMC) vectors encoding small regulatory RN
Externí odkaz:
https://doaj.org/article/f6a327b6051943f3936632a5f1af2970
Autor:
Suzan M Hammond, Graham McClorey, Joel Z Nordin, Caroline Godfrey, Sofia Stenler, Kim A Lennox, CI Edvard Smith, Ashley M Jacobi, Miguel A Varela, Yi Lee, Mark A Behlke, Matthew J A Wood, Samir E L Andaloussi
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 3, Iss C (2014)
Splice switching oligonucleotides (SSOs) induce alternative splicing of pre-mRNA and typically employ chemical modifications to increase nuclease resistance and binding affinity to target pre-mRNA. Here we describe a new SSO non-base modifier (a naph
Externí odkaz:
https://doaj.org/article/610e0a409d3146f7beb11ae6ad8495ab
Autor:
Thomas C Roberts, K Emelie M Blomberg, Graham McClorey, Samir EL Andaloussi, Caroline Godfrey, Corinne Betts, Thibault Coursindel, Michael J Gait, CI Edvard Smith, Matthew JA Wood
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 1, Iss C (2012)
MicroRNAs (miRNAs) are a class of small RNAs that regulate gene expression and are implicated in wide-ranging cellular processes and pathological conditions including Duchenne muscular dystrophy (DMD). We have compared differential miRNA expression i
Externí odkaz:
https://doaj.org/article/e9477d02be4e40489e38f8dbfc780860
Autor:
Dhanu Gupta, Doste R Mamand, Wenyi Zheng, Ci Edvard Smith, Samir El Andaloussi, Oskar Gustafsson, Daniel W. Hagey, Rula Zain, Giulia Corso, Xiuming Liang, Jeremy P Bost, André Görgens, Osama Saher
Publikováno v:
Advanced Healthcare Materials. 11:2101658
Extracellular vesicles (EVs) are nanosized cell-derived vesicles produced by all cells, which provide a route of intercellular communication by transmitting biological cargo. While EVs offer promise as therapeutic agents, the molecular mechanisms of
Autor:
Adil Doganay Duru, Giulia Corso, Ci Edvard Smith, Pieter Vader, Samir El Andaloussi, Raymond M. Schiffelers, Jeremy P Bost, Joel Z. Nordin, Mattias Hällbrink, Kärt Padari, Margus Pooga, Oscar P. B. Wiklander, Helena Sork, Eman M. Zaghloul, Helerin Margus, Matthew J.A. Wood, Burcu Bestas, Janne J. Turunen
Publikováno v:
Molecular Therapy. Nucleic Acids
Molecular therapy. Nucleic acids, 5. Nature Publishing Group
Molecular Therapy: Nucleic Acids, Vol 5, Iss C (2016)
Molecular therapy. Nucleic acids, 5. Nature Publishing Group
Molecular Therapy: Nucleic Acids, Vol 5, Iss C (2016)
The advantages of lipid-based transfection reagents have permitted their widespread use in molecular biology and gene therapy. This study outlines the effect of cryo-manipulation of a cationic lipid-based formulation, Lipofectamine 2000, which, after
Autor:
Bost JP; Department of Laboratory Medicine, Karolinska Institutet, Huddinge, 14157, Sweden. jeremy.bost@ki.se., Ojansivu M; Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, 17177, Sweden., Munson MJ; Advanced Drug Delivery, Pharmaceutical Sciences, Biopharmaceutical R&D, AstraZeneca, Mölndal, 43150, Sweden., Wesén E; Department of Biology and Biological Engineering, Chalmers University of Technology, Gothenburg, 41296, Sweden., Gallud A; Advanced Drug Delivery, Pharmaceutical Sciences, Biopharmaceutical R&D, AstraZeneca, Mölndal, 43150, Sweden.; Department of Biology and Biological Engineering, Chalmers University of Technology, Gothenburg, 41296, Sweden., Gupta D; Department of Laboratory Medicine, Karolinska Institutet, Huddinge, 14157, Sweden., Gustafsson O; Department of Laboratory Medicine, Karolinska Institutet, Huddinge, 14157, Sweden., Saher O; Department of Laboratory Medicine, Karolinska Institutet, Huddinge, 14157, Sweden.; Department of Pharmaceutics and Industrial Pharmacy, Cairo University, Cairo, 11562, Egypt., Rädler J; Department of Laboratory Medicine, Karolinska Institutet, Huddinge, 14157, Sweden., Higgins SG; Department of Materials, Department of Bioengineering, Institute of Biomedical Engineering, Imperial College London, London, SW7 2AZ, United Kingdom., Lehto T; Department of Laboratory Medicine, Karolinska Institutet, Huddinge, 14157, Sweden.; Institute of Technology, University of Tartu, Nooruse 1, Tartu, 50411, Estonia., Holme MN; Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, 17177, Sweden., Dahlén A; Discovery Sciences, R&D, AstraZeneca, Gothenburg, 43150, Sweden., Engkvist O; Discovery Sciences, R&D, AstraZeneca, Gothenburg, 43150, Sweden., Strömstedt PE; Discovery Sciences, R&D, AstraZeneca, Gothenburg, 43150, Sweden., Andersson S; Discovery Sciences, R&D, AstraZeneca, Gothenburg, 43150, Sweden., Edvard Smith CI; Department of Laboratory Medicine, Karolinska Institutet, Huddinge, 14157, Sweden., Stevens MM; Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, 17177, Sweden.; Department of Materials, Department of Bioengineering, Institute of Biomedical Engineering, Imperial College London, London, SW7 2AZ, United Kingdom., Esbjörner EK; Department of Biology and Biological Engineering, Chalmers University of Technology, Gothenburg, 41296, Sweden., Collén A; Advanced Drug Delivery, Pharmaceutical Sciences, Biopharmaceutical R&D, AstraZeneca, Mölndal, 43150, Sweden.; Projects, Research and Early Development, Cardiovascular, Renal and Metabolism, Biopharmaceuticals R&D, AstraZeneca, Gothenburg, 43150, Sweden., El Andaloussi S; Department of Laboratory Medicine, Karolinska Institutet, Huddinge, 14157, Sweden. samir.el-andaloussi@ki.se.
Publikováno v:
Communications biology [Commun Biol] 2022 Mar 01; Vol. 5 (1), pp. 185. Date of Electronic Publication: 2022 Mar 01.